Clinical Trials Logo
  1. Home
  2. Hilar Cholangiocarcinoma
  3. NCT02955771

Efficacy and Safety Study of PDT Using Deuteporfin for Unresectable Advanced Perihilar Cholangiocarcinoma

Hilar Cholangiocarcinoma Clinical Trial

Official title:
Multi-center, Randomized, Controlled, Open-label Study of Deuteporfin Photodynamic Therapy Plus Stenting Versus Stenting Alone as Treatment for Unresectable Advanced Perihilar Cholangiocarcinoma

Clinical Trial Summary

This is a multi-center, randomized, controlled, open-label, phase IIa clinical study.The study will observe the efficacy and safety of Deuteporfin photodynamic therapy in addition to stenting compared to stenting alone in patients with unresectable advanced Perihilar Cholangiocarcinoma.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT02955771
Study type Interventional
Source Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd.
Contact
Status Terminated
Phase Phase 2
Start date May 17, 2017
Completion date December 26, 2018
View Details
See also
  Status Clinical Trial Phase
Recruiting NCT05678218 - Preoperative Evaluation of Lymph Nodes of Cholangiocarcinoma
Enrolling by invitation NCT01715402 - Optimization of Health Expenditure in Liver Surgery N/A
Completed NCT03320980 - RALPPS in Patients With Hilar and Intrahepatic Cholangiocarcinoma N/A
Completed NCT00721175 - Efficacy and Cost Analysis of Plastic Stent Compare to Metallic Stent in Hilar Cholangiocarcinoma Phase 4
Recruiting NCT05626127 - MRI-based Clinico-radiomics Predicting Lymph Node Metastasis Status of Hilar Cholangiocarcinoma
Terminated NCT02082522 - Efficacy and Safety Study of PDT Using Photofrin in Unresectable Advanced Perihilar Cholangiocarcinoma (OPUS) Phase 3
Active, not recruiting NCT05239169 - Immunotherapy With Durva and Treme With or Without Capecitabine in Adjuvant Treatment for Biliary Tract Cancer Phase 2
Recruiting NCT02178280 - Safety Study of Liver Transplantation for Hilar Cholangiocarcinoma Phase 1/Phase 2
Recruiting NCT03132649 - Impact of Three-dimensional Visualization on Operation Strategy and Complications for Hilar Cholangiocarcinoma
Recruiting NCT04561453 - Feasibility Study of Multi-Platform Profiling of Resected Biliary Tract Cancer
Recruiting NCT02108145 - Percutaneous Bilateral Versus Unilateral Metal Stent for Hilar Cholangiocarcinoma Phase 2/Phase 3
Enrolling by invitation NCT03739164 - Tampa Associating Microwave Liver Ablation With Portal Vein Ligation for Staged Hepatectomy (TAMLAPS)
Recruiting NCT02801500 - Superior Bilioenteric Anastomosis by Magnetic Compressive Technique N/A
Recruiting NCT01549795 - Liver Transplantation for Hilar Cholangiocarcinoma in Association With Neoadjuvant Radio- and Chemo-therapy N/A
Recruiting NCT06106750 - Endoscopic Scissors Cutting Nasobiliary Duct VS Bilateral Plastic Stent N/A
Active, not recruiting NCT02042443 - Trametinib or Combination Chemotherapy in Treating Patients With Refractory or Advanced Biliary or Gallbladder Cancer or That Cannot Be Removed by Surgery Phase 2
Recruiting NCT05551299 - Treatment of Non-resectable Bile Duct Cancer With Radiofrequency Ablation or Photodynamic Therapy Phase 4
Completed NCT01093222 - Sorafenib Tosylate and Erlotinib Hydrochloride in Treating Patients With Locally Advanced, Unresectable, or Metastatic Gallbladder Cancer or Cholangiocarcinoma Phase 2
Enrolling by invitation NCT04779788 - I-125 Seeds Loaded Stent Insertion for Inoperable Hilar Cholangiocarcinoma N/A
Completed NCT04611100 - Efficacy of Intraductal Radiofrequency Ablation in Combination With Metallic Biliary Stenting in Advanced Hilar Cholangiocarcinoma N/A